Business
Completion of Demerger and Admission of Shares
Completion of Demerger and Admission of Shares.
About this update from Haleon Plc
[{"type":"text","content":"\n \n \n \n 18 July 2022\n \n \n \n \n Haleon plc\n \n \n \n \n \n \n \n \n \n Completion of the demerger and admission of shares in Haleon\n \n \n \n \n \n \n Haleon plc (\"Haleon\") is pleased to announce the completion of the demerger of the Consumer Healthcare business from the GSK Group to form the Haleon Group.\n \n \n \n \n \n The ordinary shares of Haleon (ticker \"LSE: HLN\") will be admitted at 8.00 a.m. today (18 July 2022) to the premium listing segment of the Official List and to trading on the main market of the London Stock Exchange (\"LSE\").\n \n \n \n \n \n CREST accounts will be credited with Haleon ordinary shares shortly after 8.00 a.m. today (18 July 2022). It is expected that Haleon shareholders with holdings in certificated form will be sent share certificates in respect of their holdings of Haleon shares by 4 August 2022.[1]\n \n \n \n \n \n On admission, Haleon will have 9,234,573,831 ordinary shares in issue. The ordinary shares have a nominal value of £1.25 each (to be reduced to 1 pence following Haleon's capital reduction)[1] and carry voting rights of one vote per share.\n \n \n \n \n \n Haleon also has in issue 25,000,000 non-voting preference shares with a nominal value of £1 each which are fully paid. The non-voting preference shares will not be listed on the LSE or any other exchanges. Haleon does not hold any shares in treasury.\n \n \n \n \n \n It is expected that American Depositary Shares representing shares of Haleon (ticker: \"NYSE: HLN\") (\"Haleon ADSs\") will commence \"regular-way\" trading on the New York Stock Exchange (the \"NYSE\") at market open on 22 July 2022. In addition, we expect that Haleon ADSs will begin trading on a \"when-issued\" basis on the NYSE from market open today up to and including 21 July 2022. Each Haleon ADS represents two Haleon ordinary shares.\n \n \n \n \n \n Further information on key dates in relation to the demerger is set out at the end of this announcement (\"Expected Timetable of Principal Events\") and can also be found in the Prospectus published on 1 June 2022. The Prospectus is available on Haleon's website at\n \n www.haleon.com\n \n .\n \n \n \n \n \n \n Ends\n \n \n \n \n \n \n \n About Haleon\n \n \n \n \n \n \n \n \n Haleon (LSE: HLN) is a global leader in consumer health, w...